Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes. [electronic resource]
Producer: 20130926Description: 109-15 p. digitalISSN:- 1872-8057
- Adult
- Aged
- Androstadienes -- pharmacology
- Animals
- Biological Transport -- drug effects
- Cells, Cultured
- Diabetes Mellitus, Type 2 -- genetics
- Female
- Flavonoids -- pharmacology
- Gene Expression Regulation -- drug effects
- Glucose -- metabolism
- Glucose Transporter Type 4 -- genetics
- Humans
- Insulin -- pharmacology
- Male
- Mice
- Mice, Knockout
- Middle Aged
- Molecular Targeted Therapy
- Muscle Cells -- drug effects
- Muscle, Skeletal -- metabolism
- Obesity -- genetics
- Peptides -- pharmacology
- Receptors, Bombesin -- agonists
- Sirolimus -- pharmacology
- Wortmannin
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.